Reference health
Elevated serum levels of anti‐Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome
25/25 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 25 checked references that resolve
resolves10.1093/humrep/deh098
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
resolves10.1016/j.fertnstert.2008.06.035
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
resolves10.1093/humrep/dep399
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
resolves10.1016/j.ajog.2006.07.046
Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome
resolves10.1016/j.ejogrb.2007.01.012
Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome
resolves10.1093/molehr/gah015
Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
resolves10.1210/jc.2003-030727
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
resolves10.1016/j.fertnstert.2009.11.002
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
resolves10.1093/humrep/dei159
Revisiting the ovarian volume as a diagnostic criterion for polycystic ovaries
resolves10.1210/jc.2005-2076
Serum Anti-Müllerian Hormone as a Surrogate for Antral Follicle Count for Definition of the Polycystic Ovary Syndrome
resolves10.1007/s00508-010-1426-x
Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome
resolves10.1210/jc.2006-2425
Serum Anti-Mullerian Hormone Concentrations Are Not Altered by Acute Administration of Follicle Stimulating Hormone in Polycystic Ovary Syndrome and Normal Women
resolves10.1210/jc.2010-0334
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
resolves10.1210/jc.2009-2106
Serum Anti-Müllerian Hormone Concentrations Are Elevated in Oligomenorrheic Girls without Evidence of Hyperandrogenism
resolves10.1507/endocrj.EJ12-0055
Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome
resolves10.1016/j.fertnstert.2005.02.052
Serum müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
resolves10.1258/000456306776865188
The LH/FSH ratio has little use in diagnosing polycystic ovarian syndrome
resolves10.1111/j.1471-0528.1992.tb14505.x
Which hormone tests for the diagnosis of polycystic ovary syndrome?
resolves10.1210/jcem-66-1-165
Hyperfunction of the Hypothalamic-Pituitary Axis in Women with Polycystic Ovarian Disease: Indirect Evidence for Partial Gonadotroph Desensitization*
resolves10.1007/s12522-011-0078-5
Serum anti‐müllerian hormone concentrations in reproductive age women with and without polycystic ovary syndrome: the influence of body mass index
resolves10.1007/s10815-011-9627-4
Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles
resolves10.1007/s12522-010-0066-1
Serum anti‐Müllerian hormone level as a predictor of poor ovarian response in in vitro fertilization patients
resolves10.3109/09513590.2012.736557
Diet, physical exercise and Orlistat administration increase serum Anti-Müllerian Hormone (AMH) levels in women with polycystic ovary syndrome (PCOS)
resolves10.3109/09513590.2012.736563
Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome
The 1 reference without a DOI — listed, not checked
no DOI — not checked1992 Blackwell Boston MA J Zawadzki A Dunaif A Dunaif J Givens F Haseltine G Merriam Diagnostic criteria for polycystic ovary syndrome: toward a rational approachPolycystic ovarian syndrome 377 84
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1111/aogs.12247"><img src="https://citestamp.com/citestamped/10.1111/aogs.12247/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1111/aogs.12247)